Neurodegeneration in autoimmune demyelination: Recent mechanistic insights reveal novel therapeutic targets
- 1 March 2007
- journal article
- review article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 184 (1-2) , 17-26
Abstract
No abstract availableKeywords
This publication has 128 references indexed in Scilit:
- Correlation of Global N-Acetyl Aspartate With Cognitive Impairment in Multiple SclerosisArchives of Neurology, 2006
- Statin Use and the Risk of Incident DementiaArchives of Neurology, 2005
- Atorvastatin for the Treatment of Mild to Moderate Alzheimer DiseaseArchives of Neurology, 2005
- Statins induce angiogenesis, neurogenesis, and synaptogenesis after strokeAnnals of Neurology, 2003
- Nitric oxide and the axonal death cascadeAnnals of Neurology, 2003
- N‐acetylaspartate: Usefulness as an indicator of viable neuronal tissueAnnals of Neurology, 2001
- Effect of Statin Therapy on C-Reactive Protein LevelsJAMA, 2001
- Decreased Prevalence of Alzheimer Disease Associated With 3-Hydroxy-3-Methyglutaryl Coenzyme A Reductase InhibitorsArchives of Neurology, 2000
- Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosisAnnals of Neurology, 1999
- Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (?)-epigallocatechin-3-gallateJournal of Cellular Biochemistry, 1999